Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period
Public ClinicalTrials.gov record NCT04452188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period (T-NOX)
Study identification
- NCT ID
- NCT04452188
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Michigan
- Other
- Enrollment
- 29 participants
Conditions and interventions
Conditions
- Cardiopulmonary Bypass
- Double Outlet Right Ventricle With Subaortic Ventricular Septal Defect and Pulmonary Stenosis
- Double Outlet Right Ventricle, Subpulmonary VSD
- Hypoplastic Left Heart Syndrome
- Pulmonary Atresia With Ventricular Septal Defect
- Tetralogy of Fallot
- Total Anomalous Pulmonary Venous Return
- Transposition of the Great Arteries
- Truncus Arteriosus
Interventions
- Normoxia (with controlled re-oxygenation) Other
- Standard of care ventilation Other
Other
Eligibility (public fields only)
- Age range
- Up to 29 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 17, 2021
- Primary completion
- Apr 19, 2023
- Completion
- Apr 19, 2023
- Last update posted
- Jun 17, 2024
2021 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04452188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04452188 live on ClinicalTrials.gov.